These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. The heritability and genetics of frontotemporal lobar degeneration. Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572 [TBL] [Abstract][Full Text] [Related]
50. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Le Ber I Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980 [TBL] [Abstract][Full Text] [Related]
51. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750 [TBL] [Abstract][Full Text] [Related]
52. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration. Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287 [TBL] [Abstract][Full Text] [Related]
53. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain. Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020 [TBL] [Abstract][Full Text] [Related]
55. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. Seelaar H; Rohrer JD; Pijnenburg YA; Fox NC; van Swieten JC J Neurol Neurosurg Psychiatry; 2011 May; 82(5):476-86. PubMed ID: 20971753 [TBL] [Abstract][Full Text] [Related]
56. [The Clinical, Pathological, and Genetic Correlation in Frontotemporal Lobar Degeneration]. Watanabe R; Arai T Brain Nerve; 2020 Jun; 72(6):575-583. PubMed ID: 32507756 [TBL] [Abstract][Full Text] [Related]
57. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years. Carlos AF; Josephs KA J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398 [TBL] [Abstract][Full Text] [Related]
58. Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration. Kawakami I; Arai T; Shinagawa S; Niizato K; Oshima K; Ikeda M Int J Geriatr Psychiatry; 2021 Jan; 36(1):38-45. PubMed ID: 32748432 [TBL] [Abstract][Full Text] [Related]
59. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP). Armstrong RA; Carter D; Cairns NJ Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412 [TBL] [Abstract][Full Text] [Related]
60. Amygdala TDP-43 Pathology in Frontotemporal Lobar Degeneration and Motor Neuron Disease. Takeda T; Seilhean D; Le Ber I; Millecamps S; Sazdovitch V; Kitagawa K; Uchihara T; Duyckaerts C J Neuropathol Exp Neurol; 2017 Sep; 76(9):800-812. PubMed ID: 28859337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]